A Multidisciplinary Approach to Management in Basal Cell Carcinoma

Playing The Offense In Advanced Basal Cell Carcinoma: A Team Approach To Treatment And Management
0.5 AMA PRA Category 1 Credit(s)
Launch Date:
December 27, 2016
Expiration Date:
The accreditation for this activity has expired.

Primary Audience:

Dermatologists and oncologists

Relevant Terms:

Basal Cell Carcinoma

Ragini Kudchadkar, MD

Ragini Kudchadkar, MD
Assistant Professor
Associate Director, Hematology/Oncology Fellowship Program
Co-Leader, Melanoma Program
Winship Cancer Institute of Emory University

Ragini Kudchadkar, MD, is an assistant professor at the Winship Cancer Institute of Emory University. Dr. Kudchadkar attended medical school and completed a residency of internal medicine at Emory University and a fellowship in hematology/oncology at the University of Colorado Health Sciences Center. Dr. Kudchadkar held positions at Moffitt Cancer Center and the College of Medicine at the University of South Florida. Her current clinical research interests focus on drug development for metastatic melanoma as well as other rare advanced cutaneous malignancies, such as basal cell carcinoma, squamous cell carcinoma, and merkel cell carcinoma. Dr. Kudchadkar’s articles have been published in a number of leading journals, including Journal of Clinical Oncology, New England Journal of Medicine, and Journal of the American Academy of Dermatology.

Clifford S. Perlis, MD

Clifford S. Perlis, MD
Abington Dermatology Associates
Jenkintown, Pennsylvania

Clifford Perlis, MD, is an adjunct associate clinical professor of dermatology at the Lewis Katz School of Medicine at Temple University, a private practice Mohs surgeon in suburban Philadelphia, and an associate editor of the Journal of the American Academy of Dermatology. He is also the former director of dermatological surgery and former chairman of the Institutional Review Board at Fox Chase Cancer Center. Dr. Perlis attended medical school at the University of Pennsylvania. After completing a general surgery internship at the Hospital of the University of Pennsylvania, Dr. Perlis was a dermatology resident and fellow in Mohs surgery and cutaneous oncology at Brown University. His current research interests include cutaneous oncology, non-invasive imaging, and medical ethics.
1. Implement effective treatment options for advanced and metastatic basal cell carcinoma (BCC) based on efficacy data and current guidelines
2. Recognize, prevent, and manage safety issues when treating advanced or metastatic BCC, especially with prolonged treatment
3. Utilize communication and patient education strategies in order to optimize patient involvement in informed treatment decision making as well as prevention and early recognition of side effects and disease progression
4. Integrate into practice effective care coordination strategies for treating patients with BCC, including input from multidisciplinary members of the healthcare team as well as patients and caregivers

Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Postgraduate Institute for Medicine and RMEI Medical Education, LLC. The Postgraduate Institute for Medicine is accredited by the ACCME to provide continuing medical education for physicians.
Credit Designation
The Postgraduate Institute for Medicine designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.
The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:
  • Ragini Kudchadkar, MD, has affiliations with Bristol-Myers Squibb (Consulting Fees).  
  • Clifford S. Perlis, MD, has no affiliations with commercial interests to disclose.   
RMEI Medical Education, LLC
  • Jayashree Gokhale, PhD, has no affiliations with commercial interests to disclose. 
  • Jacqui Brooks, MBBCh, MRCPsych, has no affiliations with commercial interests to disclose.
  • Amy Reeve has no affiliations with commercial interests to disclose. 
  • Kyra Sheahan has no affiliations with commercial interests to disclose.
Postgraduate Institute for Medicine
The following PIM planners and managers, Judi Smelker-Mitchek, RN, BSN, Trace Hutchison, PharmD, Samantha Mattiucci, PharmD, CHCP, and Jan Schultz, MSN, RN, CHCP, hereby state that they or their spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients' conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. 
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Estimated time to complete: 0.5 hours
Medium: Internet

There is no fee for this educational activity.

This activity is jointly provided by Postgraduate Institute for Medicine and RMEI Medical Education, LLC. This activity is supported by an independent educational grant from Genentech.

By reviewing the course content and successfully completing the post-test and evaluation, physicians, nurse practitioners, and physician assistants are entitled to receive up to 0.5 AMA PRA Category 1 Credit(s)™. A statement of credit will be available to print from your user history page. Users must:
  • Read the learning objectives and faculty disclosures.
  • Participate in the activity.
  • Complete the activity evaluation.
Physicians, nurse practitioners, and physician assistants who successfully complete the post-test and evaluation will receive CME credit. You must score 75% or higher on the post-test to receive credit for this activity. All other participants who successfully complete the post-test and evaluation will receive a certificate of participation.
Supported Browsers:
Internet Explorer 9.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6.0+ for Mac OSX 10.7 and above
Supported Phones & Tablets:
Android 4.0.3 and above
iPhone/iPad with iOS 6.1 or above.